Diagnostic testing for SARS-CoV-2 is crucial in the management of the COVID-19 pandemic. According to the Public Health Agency of Canada (PHAC), nasopharyngeal swabs are the specimen of choice for routine testing for SARS-CoV-2. 1 Nasopharyngeal swabbing is an uncomfortable procedure, which may decrease patient willingness to comply with repeat testing, and increase use of health care personnel, costs and exposure risk. 2,3 The need for mass testing also creates bottlenecks in sample collection and depletes availability of protective equipment. Therefore, alternative testing methods are needed.Salivary testing has been proposed as an alternative to nasopharyngeal swabs. We previously compared detection rates of nasopharyngeal swabs with self-collection saliva kits for SARS-CoV-2 in adults. 4 However, limited literature is available to support salivary testing in the pediatric population, and those published show conflicting results. Select studies show similar detection between the 2 approaches, with a high sensitivity of saliva when using nasopharyngeal as a reference standard. 2,[5][6][7] In contrast, other studies found lower rates, but were limited by small sample sizes. 8,9 Further more, no studies to date have evaluated the optimum timing for testing after exposure or symptom onset in the adult or pediatric populations. Previous studies have shown variability of results produced at different time points. 10 New studies are needed to determine the optimum timing for testing for these diagnostic modalities.To date, children younger than 19 years account for about 20% of SARS-CoV-2 infections in Canada. 11 As such, the need for effective and reliable repeat sampling in children is critical as restrictions ease and the prevalence of variants of concern increases, especially for distinguishing SARS-CoV-2 infection from other respiratory pathogens in children. As a less invasive testing method, saliva testing may prove an effective alternative to repeat testing by nasopharyngeal swab